CAMLG antibody
Quick Overview for CAMLG antibody (ABIN7257333)
Target
See all CAMLG AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Characteristics
- Polyclonal Antibody
-
Purification
- Affinity purification
-
Immunogen
- Recombinant fusion protein of human CAMLG (NP_001736.1).
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB 1:500-1:2000 IHC 1:50-1:100 IF 1:50-1:200
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- CAMLG (Calcium Modulating Ligand (CAMLG))
-
Alternative Name
- CAMLG
-
Background
- The immunosuppressant drug cyclosporin A blocks a calcium-dependent signal from the T-cell receptor (TCR) that normally leads to T-cell activation. When bound to cyclophilin B, cyclosporin A binds and inactivates the key signaling intermediate calcineurin. The protein encoded by this gene functions similarly to cyclosporin A, binding to cyclophilin B and acting downstream of the TCR and upstream of calcineurin by causing an influx of calcium. This integral membrane protein appears to be a new participant in the calcium signal transduction pathway, implicating cyclophilin B in calcium signaling, even in the absence of cyclosporin.
-
Molecular Weight
-
Observed_MW: 38 kDa
Calculated_MW: 32 kDa
-
Gene ID
- 819
-
UniProt
- P49069
-
Pathways
- EGFR Signaling Pathway
Target
-